View Older Stories View More Recent Stories
-
Solid growth seen for South Korea December exports, aided by memory chips: Reuters poll
-
East to West - The Chinese Model gains traction in the global manufacturing industry
-
EU Follows US and Approves Chugai's ALK Inhibitor "Alecensa®" as First Line Therapy for ALK-Positive Non-Small Cell Lung Cancer
-
Singapore November industrial output growth seen at six-month low: Reuters poll
-
DNV GL: Energy Transition Changes the Shape, but not the Importance of Shipping to the Global Economy
-
THERADIAG Provides an Update on Prestizia and Its Partnership with HOB Biotech
-
2017 Closes With Strong Commercial And Industrial Activity Suggesting Healthy Business Growth Through Third Quarter 2018
-
DEINOVE Launches the Industrial Production of Its First Carotenoid
-
Thailand Extends Corporate Tax Exemption
-
U.S. industrial output increases 0.2 percent in November
-
Industrial Production (Nov. MoM) 0.2% vs 0.3% Expected; Capacity Utilization 77.1% vs 77.2%
-
Nucor (NUE) Guides Q4 EPS Below Views
-
Nucor Announces Guidance For Its Fourth Quarter Earnings
-
ISM® Reports Economic Growth To Continue In 2018
-
Schneider Electric accelerates fight against climate change at One Planet Summit
-
The Conference Board Employment Trends Index™ (ETI) Declined in November
-
UK industry surges, construction and trade muddy outlook
-
French industrial output surges unexpectedly in October
-
Holidays sink German industrial output in October
-
Chugai's Emicizumab Every Four Weeks Showed Positive Interim Results in Phase III Study
-
China local govts should intervene on rising cement prices - industry body
-
TD Ameritrade Investor Movement Index: IMX Rises Over 15 Percent to New Record High
-
GroupM: Global Ad Investment Will Grow 4.3% in 2018; Six Countries to Drive 68% of Incremental Investment
-
ITEC Entertainment Structures for Faster Growth in China
-
PMI® at 58.2%; November Manufacturing ISM® Report On Business®
-
RTI CEO to Speak at Industrial Internet Consortium (IIC) IIoT World Tour Event
-
Japan October industrial output rebounds, manufacturers see good times ahead
-
Indian economic growth set to end five-quarter slide: Reuters poll
-
Japan government keeps view that moderate economic recovery continuing
-
Safe Ports Regional Gateway, a Secure and Economical Hub to Spur Global Business Activity in the Middle East, Launches at Crossroads Site in Jordan
-
Chemical Activity Barometer Continues Solid Gains Into 3rd Quarter
-
DEINOVE and GREENTECH Are Making Progress in the Co-Development of Their Cosmetic Active Ingredient
-
Chugai's Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study
-
IIoT World Tour Stops in San Francisco on December 8
-
Chugai's HEMLIBRA® Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors
-
Germany Trade and Invest: Growth - Manufactured in Germany
-
Industrial Production (Oct. MoM) 0.9% vs 0.5% Expected
-
U.S. industrial output surges as hurricane-related disruptions fade
-
Country Garden Forest City wins the SCAHSA award for the second consecutive year
-
City of Dresden: Billions Invested in IoT Technologies in Dresden
-
Euro zone growth, eclipsing U.S. economy, set to be best in decade
-
China's economy cools as government curbs hit factories, property and retailers
-
Euro soars on strong economic growth in Germany
-
CARMAT Signs a Partnership Agreement with AddUp, the Michelin and Fives Joint Venture Specialized in 3D Printing
-
Lubrizol Joins HP's Open Materials and Applications Platform to Advance Estane® Engineered Polymers in 3DP Applications
-
BTS Launches New Sales Index, a Predictive Monthly Metric for Business Leaders, and Releases October Index Numbers
-
Reply Launches Comprehensive Industrie 4.0 Solutions for Flexible and Connected Manufacturing
-
China's strong factory gate inflation shows economic momentum still robust
-
Methanex Signs a Long-Term Natural Gas Supply Agreement With Painted Pony Energy Ltd. for Its Existing Methanol Plant in Medicine Hat, Alberta
-
Chugai's ALK Inhibitor "Alecensa®" Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in the US

